
pmid: 7369744
Two patients with lobular lymphohistiocytic panniculitis had chronic lesions that produced subcutaneous atrophy and that were responsive to antimalarial drugs. Massive lymphocytic infiltrate was associated with caseation necrosis of the fat lobules. In both patients, an unusual antibody to extractable nuclear antigen was seen, and antinuclear antibody was sometimes present. The unusual manifestation, course of the disease, serologic findings, and response to therapy suggest that the panniculitis is related to (but does not evolve into) lupus erythematosus panniculitis or subcutaneous morphea or both. A satisfactory term for this entity would be "connective tissue panniculitis."
Adult, Shoulder, Adolescent, Biopsy, Leukopenia, Skin Diseases, Antigen-Antibody Reactions, Panniculitis, Nodular Nonsuppurative, Scleroderma, Localized, Lupus Erythematosus, Discoid, Adipose Tissue, Humans, Prednisone, Female, Fat Necrosis, Atrophy, Connective Tissue Diseases, Hydroxychloroquine, Skin
Adult, Shoulder, Adolescent, Biopsy, Leukopenia, Skin Diseases, Antigen-Antibody Reactions, Panniculitis, Nodular Nonsuppurative, Scleroderma, Localized, Lupus Erythematosus, Discoid, Adipose Tissue, Humans, Prednisone, Female, Fat Necrosis, Atrophy, Connective Tissue Diseases, Hydroxychloroquine, Skin
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 68 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
